Human Langerhans cells selectively activated via Toll-like receptor 2 agonists acquire migratory and CD4+T cell stimulatory capacity

Journal of Leukocyte Biology

Volumn 83, Issue 5, 2008, Pages 1118-1127

  Peiser, Matthias ^a   Koeck, Juliana ^b   Kirschning, Carsten J ^c   Wittig, Burghardt ^a   Wanner, Reinhard ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b DEUTSCHES RHEUMA FORSCHUNGSZENTRUM   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Chemotaxis; Dendritic cell; Lipopeptide; Peptidoglycan; Skin; TLR2

Indexed keywords

BACTERIAL PROTEIN; BACTERIUM LIPOPOLYSACCHARIDE; CD1C ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; CHEMOKINE RECEPTOR CCR7; CPG OLIGODEOXYNUCLEOTIDE; FLAGELLIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; INTERLEUKIN 6; LANGERIN; LIPOPEPTIDE; MACROPHAGE ACTIVATING LIPOPEPTIDE 2; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; MONOCLONAL ANTIBODY; PEPTIDOGLYCAN; POLYINOSINIC POLYCYTIDYLIC ACID; SECONDARY LYMPHOID TISSUE CHEMOKINE; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA;

AGONIST; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMAN CELL; INFLAMMATION; LANGERHANS CELL; LYMPHOCYTE MIGRATION; MONOCYTE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; T LYMPHOCYTE ACTIVATION; UPREGULATION;

CD4-POSITIVE T-LYMPHOCYTES; CELL MOVEMENT; EPIDERMIS; FLOW CYTOMETRY; HUMANS; INFLAMMATION; INTERLEUKIN-6; LANGERHANS CELLS; LIPOPROTEINS; LYMPHOCYTE ACTIVATION; NF-KAPPA B; TOLL-LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR-ALPHA;

BACTERIA (MICROORGANISMS);

EID: 46749140431     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0807567     Document Type: Article

References (42)

1. Medzhitov, R., Preston-Hurlburt, P., Janeway Jr., C. A. (1997) A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388, 394-397.
2. Janeway, C. A., Medzhitov, R. (2002) Innate immune recognition. Annu. Rev. Immunol. 20, 197-216.
3. Takeda, K., Kaisho, T., Akira, S. (2003) Toll-like receptors. Annu. Rev. Immunol. 21, 335-376.
4. Takeda, K., Akira, S. (2005) Toll-like receptors in innate immunity. Int. Immunol. 17, 1-14.
5. Iwasaki, A., Medzhitov, R. (2004) Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 5, 987-995.
6. Dieu, M. C., Vanbervliet, B., Vicari, A., Bridon, J. M., Oldham, E., Ait-Yahia, S., Briere, F., Zlotnik, A., Lebecque, S., Caux, C. (1998) Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J. Exp. Med. 188, 373-386.
7. Peiser, M., Wanner, R., Kolde, G. (2004) Human epidermal Langerhans cells differ from monocyte-derived Langerhans cells in CD80 expression and in secretion of IL-12 after CD40 crosslinking. J. Leukoc. Biol. 76, 616-622.
8. Uematsu, S., Akira, S. (2006) Toll-like receptors and innate immunity. J. Mol. Med. 84, 712-725.
9. Schwandner, R., Dziarski, R., Wesche, H., Rothe, M., Kirschning, C. J. (1999) Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by Toll-like receptor 2. J. Biol. Chem. 274, 17406-17409.
10. Aliprantis, A. O., Yang, R. B., Mark, R. M., Suggett, S., Devaux, B., Radolf, D. J., Klimpel, R. G., Godowski, P., Zychlinsky, A. (1999) Cell activation and apoptosis by bacterial lipoproteins through Toll-like receptor-2. Science 285, 736-739.
11. Morr, M., Takeuchi, O., Akira, S., Simon, M. M., Muhlradt, P. F. (2002) Differential recognition of structural details of bacterial lipopeptides by Toll-like receptors. Eur. J. Immunol. 32, 3337-3347.
12. Takeuchi, O., Sato, S., Horiuchi, T., Hoshino, K., Takeda, K., Dong, Z., Modlin, R. L., Akira, S. (2002) Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. J. Immunol. 169, 10-14.
13. Takeuchi, O., Kawai, T., Muhlradt, P. F., Morr, M., Radolf, J. D., Zychlinsky, A., Takeda, K., Akira, S. (2001) Discrimination of bacterial lipoproteins by Toll-like receptor 6. Int. Immunol. 13, 933-940.
14. Peiser, M., Grützkau, A., Wanner, R., Kolde, G. (2003) CD1a and CD1c cell sorting yields a homogeneous population of immature enriched human Langerhans cells. J. Immunol. Methods 279, 41-53.
15. Geissmann, F., Prost, C., Monnet, J. P., Dy, M., Brousse, N., Hermine, O. (1998) Transforming growth factor β1, in the presence of granulocyte/ macrophage colony-stimulating factor and interleukin 4, induces differentiation of human peripheral blood monocytes into dendritic Langerhans cells. J. Exp. Med. 187, 961-966.
16. Luft, T., Maraskovsky, E., Schnurr, M., Knebel, K., Kirsch, M., Görner, M., Skoda, R., Ho, A. D., Nawroth, P., Bierhaus, A. (2004) Tuning the volume of the immune response: strengh and persistence of stimulation determine migration and cytokine secretion of dendritic cells. Blood 104, 1066-1074.
17. Akira, S., Takeda, K. (2004) Toll-like receptor signaling. Nat. Rev. Immunol. 4, 499-511.
18. Cella, M., Scheidegger, D., Palmer-Lehmann, K., Lane, P., Lanzavecchia, A., Alber, G. (1996) Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J. Exp. Med. 184, 747-752.
19. Querec, T., Bennouna, S., Alkan, S., Laouar, Y., Gorden, K., Flavell, R., Akira, S., Ahmed, R., Pulendran, B. (2006) Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity. J. Exp. Med. 203, 413-424.
20. Napolitani, G., Rinaldi, A., Bertoni, F., Sallusto, F., Lanzavecchia, A. (2005) Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells. Nat. Immunol. 6, 769-776.
21. Kadowaki, N., Ho, S., Antonenko, S., Malefyt, R. W., Kastelein, R. A., Bazan, F., Liu, Y. J. (2001) Subsets of human dendritic cell precursors express different Toll-like receptors and respond to different microbial antigens. J. Exp. Med. 194, 863-869.
22. Takeuchi, J., Watari, E., Shinya, E., Norose, Y., Matsumoto, M., Seya, T., Sugita, M., Kawana, S., Takahashi, H. (2003) Down-regulation of Toll-like receptor expression in monocyte-derived Langerhans cell-like cells: implications of low-responsiveness to bacterial components in epidermal Langerhans cells. Biochem. Biophys. Res. Commun. 306, 674-679.
23. Renn, C. N., Sanchez, D. J., Ochoa, M. T., Legaspi, A. J., Oh, C. K., Liu, P. T., Krutzik, S. R., Sieling, P. A., Cheng, G., Modlin, R. L. (2006) TLR activation of Langerhans cell-like dendritic cells triggers an antiviral immune response. J. Immunol. 177, 298-305.
24. Flacher, V., Bouschbacher, M., Verronese, E., Massacrier, C., Sisirak, V., Berthier-Vergnes, O., de Saint-Vis, B., Caux, C., Dezutter-Dambuyant, C., Lebecque, S., Valladeau, J. (2006) Human Langerhans cells express a specific TLR profile and differentially respond to viruses and Grampositive bacteria. J. Immunol. 177, 7959-7967.
25. Van der Aar, A. M., Sylva-Steenland, R. M., Bos, J. D., Kapsenberg, M. L., de Jong, E. C., Teunissen, M. B. (2007) Loss of TLR2, TLR4, and TLR5 on Langerhans cells abolishes bacterial recognition. J. Immunol. 178, 1986-1990.
26. Flo, T. H., Halaas, Ø., Torp, S., Ryan, L., Lien, E., Dybdahl, B., Sundan, A., Espevik, T. (2001) Differential expression of Toll-like receptor 2 in human cells. J. Leukoc. Biol. 69, 474-481.
27. Jarrossay, D., Napolitani, G., Colonna, M., Sallusto, F., Lanzavecchia, A. (2001) Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells. Eur. J. Immunol. 31, 3388-3393.
28. Mitsui, H., Watanabe, T., Saeki, H., Mori, K., Fujita, H., Tada, Y., Asahina, A., Nakamura, K., Tamaki, K. (2004) Differential expression and function of Toll-like receptors in Langerhans cells: comparison with splenic dendritic cells. J. Invest. Dermatol. 122, 95-102.
29. Matsuguchi, T., Musikacharoen, T., Ogawa, T., Yoshikai, Y. (2000) Gene expressions of Toll-like receptor 2, but not Toll-like receptor 4, is induced by LPS and inflammatory cytokines in mouse macrophages. J. Immunol. 165, 5767-5772.
30. Schulz, O., Edwards, A. D., Schito, M., Aliberti, J., Manickasingham, S., Sher, A., Reis e Sousa, C. (2000) CD40 triggering of heterodimeric IL-12p70 production by dendritic cells in vivo requires a microbial priming signal. Immunity 13, 453-462.
31. Hertz, C. J., Kiertscher, S. M., Godowski, P. J., Bouis, D. A., Norgard, M. V., Roth, M. D., Modlin, R. L. (2001) Microbial lipopeptides stimulate dendritic cell maturation via Toll-like receptor 2. J. Immunol. 166, 2444-2450.
32. Jakob, T., Udey, M. C. (1998) Regulation of E-cadherin-mediated adhesion in Langerhans cell-like dendritic cells by inflammatory mediators that mobilize Langerhans cells in vivo. J. Immunol. 160, 4067-4073.
33. Caux, C., Dezutter-Dambuyant, C., Schmitt, D. (1992) GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells. Nature 360, 258-261.
34. Caux, C., Massacrier, C., Vanbervliet, B., Dubois, B., Van Kooten, C., Durand, I., Banchereau, J. (1994) Activation of human dendritic cells through CD40 cross-linking. J. Exp. Med. 180, 1263-1272.
35. Peguet-Navarro, J., Dalbiez-Gauthier, C., Rattis, F. M., Van Kooten, C., Banchereau, J., Schmitt, D. (1995) Functional expression of CD40 antigen on human epidermal Langerhans cells. J. Immunol. 155, 4241-4247.
36. + blood dendritic cells induce antigen-specific cytotoxic T lymphocytes with similar efficiency compared to monocyte-derived dendritic cells despite higher levels of MHC class I expression. J. Immunother. 29, 596-605.
37. Bauer, J., Bahmer, F. A., Wörl, J., Neuhuber, W., Schuler, G., Fartasch, M. (2001) A strikingly constant ratio exists between Langerhans cells and other epidermal cells in human skin. A stereologic study using the optical disector method and the confocal laser scanning microscope. J. Invest. Dermatol. 116, 313-318.
38. Liu, C., Gelius, E., Liu, G., Steiner, H., Dziarski, R. (2000) Mammalian peptidoglycan recognition protein binds peptidoglycan with high affinity, is expressed in neutrophils, and inhibits bacterial growth. J. Biol. Chem. 275, 24490-24499.
39. Chamaillard, M., Hashimoto, M., Horie, Y., Masumoto, J., Qiu, S., Saab, L., Ogura, Y., Kawasaki, A., Fukase, K., Kusumoto, S., Valvano, M. A., Foster, S. J., Mak, T. W., Nunez, G., Inohara, N. (2003) An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid. Nat. Immunol. 4, 702-707.
40. Girardin, S. E., Boneca, I. G., Carneiro, L. A., Antignac, A., Jehanno, M., Viala, J., Tedin, K., Taha, M. K., Labigne, A., Zahringer, U., Coyle, A. J., DiStefano, P. S., Bertin, J., Sansonetti, P. J., Philpott, D. J. (2003) Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan. Science 300, 1584-1587.
41. Meng, G., Rutz, M., Schiemann, M., Metzger, J., Grabiec, A., Schwandner, R., Luppa, P. B., Ebel, F., Busch, D. H., Bauer, S., Wagner, H., Kirschning, C. J. (2004) Antagonistic antibody prevents Toll-like receptor 2-driven lethal shock-like syndromes. J. Clin. Invest. 113, 1473-1481.
42. Borsutzky, S., Fiorelli, V., Ebensen, T., Tripiciano, A., Rharbaoui, F., Scoglio, A., Link, C., Nappi, F., Morr, M., Butto, S., Cafaro, A., Muhlradt, P. F., Ensoli, B., Guzman, C. A. (2003) Efficient mucosal delivery of the HIV-1 Tat protein using the synthetic lipopeptide MALP2 as adjuvant. Eur. J. Immunol. 33, 1548-1556.